13F GuideFiling Basics
What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
AlphaSMO Research GuideRead Guide
CIK: 0001882053
Total reported value
$427.5M
$427.5M
21 檔
47.5%
The Q1 2024 SEC filing reveals that Boone Capital Management LLC held a total portfolio value of $427.5M, covering 21 public equity positions.
During Q1 2024, Boone Capital Management LLC's portfolio maintained high stability with no major positional turnover, reflecting a continuous long-term holding approach.
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | UNM | Unum Group | Stock-Financials | 11.12% | — | +6.59% | |
| 2 | CI | THE Cigna Group | Stock-Healthcare | 9.69% | -0.97% | +47.17% | |
| 3 | MOH | Molina Healthcare Inc | Stock-Healthcare | 7.12% | — | +25.52% | |
| 4 | ENOV | Enovis CORP | Stock-Other | 7.11% | — | — | |
| 5 | BAX | Baxter International Inc | Stock-Healthcare | 6.03% | — | +27.24% | |
| 6 | GMED | Globus Medical Inc - A | Stock-Healthcare | 5.75% | — | — | |
| 7 | BERYEUR | Berry Global Group Inc | Stock-Other | 5.51% | — | +94.47% | |
| 8 | AMPH | Amphastar Pharmaceuticals In | Stock-Other | 5.39% | — | +51.67% | |
| 9 | VKTX | Viking Therapeutics Inc | Stock-Healthcare | 5.15% | — | — | |
| 10 | BIO | Bio-rad Laboratories-a | Stock-Healthcare | 5.06% | — | +102.57% | |
| 11 | IDYA | Ideaya Biosciences Inc | Stock-Other | 4.72% | — | — | |
| 12 | TARS | Tarsus Pharmaceuticals Inc | Stock-Other | 4.48% | — | — | |
| 13 | DHR | Danaher CORP | Stock-Healthcare | 3.32% | — | -39.35% | |
| 14 | MLAB | Mesa Laboratories Inc | Stock-Other | 2.96% | — | +108.22% | |
| 15 | OFIX | Orthofix Medical Inc | Stock-Other | 2.86% | — | +94.90% | |
| 16 | VTRS | Viatris Inc | Stock-Healthcare | 2.74% | — | -40.72% | |
| 17 | XENE | Xenon Pharmaceuticals Inc | Stock-Other | 2.54% | — | +14.08% | |
| 18 | HCSG | Healthcare Services Group | Stock-Other | 2.34% | — | — | |
| 19 | MIRM | Mirum Pharmaceuticals Inc | Stock-Other | 2.30% | -0.54% | -7.80% | |
| 20 | PNTG | Pennant Group Inc/the | Stock-Other | 2.24% | +4.46% | NEW | |
| 21 | QTRX | Quanterix CORP | Stock-Other | 1.57% | — | -41.93% |
According to official SEC Form 13F filings, Boone Capital Management LLC reported a total U.S. public equity portfolio value of $427.5M across 21 disclosed positions in Q1 2024.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
In terms of portfolio concentration, the top 5 core holdings (including UNM, CI, MOH) accounted for 47.5% of total reported equity market value during Q1 2024.
During Q1 2024, Boone Capital Management LLC's top holdings by market value included UNM (11.1%)、CI (9.7%)、MOH (7.1%). The largest single position, UNM, represented 11.1% of total portfolio value.
In Q1 2024, Boone Capital Management LLC made 0 total portfolio adjustments, initiating 0 new buys, adding to 0 positions, trimming 0 holdings, and fully liquidating 0 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.